Literature DB >> 14051497

CLINICAL EXPERIENCE WITH VINCRISTINE.

D M WHITELAW, D H COWAN, F R CASSIDY, T A PATTERSON.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; HODGKIN'S DISEASE; LYMPHOSARCOMA; NEUROLOGIC MANIFESTATIONS; SARCOMA, RETICULUM CELL; TOXICOLOGIC REPORT; VINCRISTINE

Mesh：

Substances：

Year:  1963        PMID： 14051497

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

Review 1.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

Review 3.  Vincristine neurotoxicity. Pathophysiology and management.

Authors:  S S Legha
Journal:  Med Toxicol       Date:  1986 Nov-Dec

4.  Coma associated with vincristine therapy.

Authors:  J A Whittaker; D H Parry; C Bunch; D J Weatherall
Journal:  Br Med J       Date:  1973-11-10

5.  An investigation of the mouse as a model for vincristine toxicity.

Authors:  S D Harrison
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.